Browse By: Country ι Category ι Tag

Liver Cancer Market Research Reports

Global Liver Cancer Partnering 2010 to 2017
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: Feb 2017
Published By: Current Partnering

Price: $1495
Metastatic Liver Cancer-Pipeline Insights, 2017
DelveInsight’s, “ Metastatic Liver Cancer-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic Liver Cancer. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Metastatic Liver Cancer. DelveInsight’s Report also assesses the Metasta
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Liver cancer- Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 5-7 business days to complete. DelveInsight’s Liver cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Liver cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Liver cancer till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Liver cancer market. • I
Published Date: Jan 2017
Published By: DelveInsight

Price: $4950
Liver cancer- Epidemiology Forecast To 2023
Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication. Scope of the Report • The Report includes the prevalent population and how will it change over the next eight years. • Prevalent or incident cases segmented by age and sex. • Coverage of key Liver cancer subpopulations and its prevalent or incident cases • The key differences in epidemiology patterns across the seven market segments Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Liver cancer market. • Identifying prevalent patient populations as well as risk factors in the global Liv
Published Date: Jan 2017
Published By: DelveInsight

Price: $2750
Liver Cancer - Pipeline Review, H2 2016
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of the Liver Cancer (Oncology) pipeline landscape. Liver cancer starts in the liver. The risk factors for liver cancer include hepatitis, cirrhosis, or scarring of liver, being male and having low weight at birth. Symptoms include a lump or pain on the right side of the abdomen and yellowing of the skin. Treatment of liver cancer may include chemotherapy, radiation and surgery. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Liver Cancer (Oncology), complete with ana
Published Date: Dec 2016
Published By: Global Markets Direct

Price: $2500
Liver cancer - Epidemiology Forecast To 2023
Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication. Scope of the Report • The Report includes the prevalent population and how will it change over the next eight years. • Prevalent or incident cases segmented by age and sex. • Coverage of key Liver cancer subpopulations and its prevalent or incident cases • The key differences in epidemiology patterns across the seven market segments Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Liver cancer market. • Identifying prevalent patient populations as well as risk factors in the global Liv
Published Date: Nov 2016
Published By: DelveInsight

Price: $2750
Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016
Summary GlobalData's Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Liver Cancer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Liver Cancer Diagnostic Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry expe
Published Date: Sep 2016
Published By: GlobalData

Price: $4000
Computer Aided Detection Market (Imaging Modality -Imaging Modality, Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT; Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bone Cancer) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
Computer aided detection (CAD) is a clinically established tool that helps in the diagnosis or detection of cancers, and cardiovascular and neurological diseases. These systems assist physicians to decrease false negative rate, detect cancer at early stages, reduce mortality rates caused due to cancer and other diseases, and improve inter and intra reader variability. 
Published Date: Aug 2016
Published By: Transparency

Price: $5795
Liver cancer- Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 7-10 business days to complete. DelveInsight’s Liver cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Liver cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Liver cancer till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Liver cancer market. • Identif
Published Date: Aug 2016
Published By: DelveInsight

Price: $4950
Liver Cancer - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Liver Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Liver Cancer and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe co
Published Date: Jun 2016
Published By: Global Markets Direct

Price: $2500
Global Liver Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Liver cancer - Market Insights, Epidemiology and Market Forecast-2020
Note*: This report requires 5-10 business days to complete. DelveInsight’s Liver cancer - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and global market trends of the %Indication"% for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Liver cancer forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Liver cancer till 2020. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Liver cancer market. • Iden
Published Date: Apr 2016
Published By: DelveInsight

Price: $4950
Metastatic Liver Cancer-Pipeline Insights, 2016
DelveInsight’s, “ Metastatic Liver Cancer-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic Liver Cancer. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Metastatic Liver Cancer. DelveInsight’s Report also assesses the Metastatic
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Liver Cancer - Pipeline Review, H2 2015
Summary Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H2 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liver Cancer and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Dec 2015
Published By: Global Markets Direct

Price: $2500
Metastatic Liver Cancer - Pipeline Review, H2 2015
Summary Global Markets Direct’s, ‘Metastatic Liver Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Liver Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Liver Cancer and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly
Published Date: Oct 2015
Published By: Global Markets Direct

Price: $2000
Liver Cancer - Pipeline Review 2015
Summary GlobalData's Medical Devices sector report, “Liver Cancer - Pipeline Review, 2015" provides an overview of Liver Cancer diagnostic tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Liver Cancer diagnostic tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. *Note: Certain sections in the
Published Date: Oct 2015
Published By: GlobalData

Price: $4000
Liver Cancer - Pipeline Review, H1 2015
Liver Cancer - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Liver Cancer - Pipeline Review, H1 2015, provides an overview of the Liver Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liver Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Jun 2015
Published By: Global Markets Direct

Price: $2500
Metastatic Liver Cancer-Pipeline Insights, 2015
SUMMARYDelveInsights, Metastatic Liver Cancer-Pipeline Insights, 2015, report provides comprehensive insights about pipeline drugs across this Metastatic Liver Cancer. A key objective of DelveInsights report is to establish the understanding for all the pipeline drugs that fall under Metastatic Liver Cancer. The report provides information on the therapeutic development based on the Metastatic Liver Cancer providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsights Report is assessing the Metastatic Liver Cancer therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. In addition to this, thereport has covered the key players and their financial details. DelveInsights Reports are also highlighting
Published Date: Apr 2015
Published By: DelveInsight

Price: $1250
Metastatic Liver Cancer - Pipeline Review, H1 2015
Global Markets Directs, Metastatic Liver Cancer Pipeline Review, H1 2015, provides an overview of the Metastatic Liver Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Liver Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. T
Published Date: Mar 2015
Published By: Global Markets Direct

Price: $2000
Liver Cancer Partnering 2010-2015
The Liver Cancer Partnering 2010-2015 report provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in liver cancer partnering deals Top Liver cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Liver Cancer Partnering 2010-2015 provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of liver cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors Liver cancer technology. These deals tend to be mu
Published Date: Mar 2015
Published By: Current Partnering

Price: $795

Upcoming Reports

Wheelchair Accessible Vehicle Converters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Vehicles which are converted in a way that have easy access for wheelchairs are termed as wheelchair accessible vehicles or WAV’s. The vehicles are specially converted from a standard vehicle to WAV in order to accommodate the wheelchair. Wheelchair accessible vehicles are considered as mult
Published By: Transparency
Price: $5795
Enteral Nutrition Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Enteral nutrition pumps also known as enteral feeding pumps are used to deliver nutritious foods containing carbohydrate, protein, fat, vitamin, minerals and water by inserting directly into the stomach or parts of small intestine. Enteral nutrition pumps are recommended to patients suffering from
Published By: Transparency
Price: $5795
Residential Water Treatment Equipment Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2014 - 2020
Increasing industrial and environmental pollution around the world is increasing the need for water treatment. Water pollution due to increasing industrialization and environment pollution is leading to death and spread of diseases. It also adversely affects more than 1 billion of population every
Published By: Transparency
Price: $5795
Steam Boiler System Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
The growing need of effective heating systems as well as the requirement of increasing operating efficiency of residential and commercial complexes has led to the widespread adoption of steam boiler systems. This technology provides high steam temperature and improved pressure parameters to achiev
Published By: Transparency
Price: $5795
Seismic Survey Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
Increasing exploration activities owing to the efforts of oil and gas companies to locate new oil and gas reserves is expected to drive the global seismic survey market during the forecast period. Oil and gas companies use seismic surveys to map and interpret potential petroleum reserves.  P
Published By: Transparency
Price: $5795

Back To Top